Viewing Study NCT05569057


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-29 @ 10:02 AM
Study NCT ID: NCT05569057
Status: UNKNOWN
Last Update Posted: 2022-10-07
First Post: 2022-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module